Emerging leader in orthopedic trauma and reconstruction products selects clinivation Global xi to manage its medical products approvals and submissions worldwide.
Framingham, MA, March 30, 2007 – clinivation, Inc. announced today that Acumed LLC has selected the clinivation Global Enterprise Solution for Market Clearance Management Market Clearance Management solution.
“Acumed is clearly an emerging leader in orthopedic trauma and reconstruction products for the upper and lower extremities, and we are pleased they have selected clinivation Global xi to impact market clearance operations to better achieve sales and marketing objectives,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer.
Clinivation Global xi software enables medical device companies to sell more products to more countries faster and easier than ever before. Clinivation Global xi is the first complete solution targeted at automating the business processes for market clearance operations worldwide.
About Acumed LLC
Acumed designs innovative orthopedic implants that help surgeons heal broken bones. Based in Hillsboro, Oregon, Acumed’s mission is to aid the afflicted through the ingenuity of our minds, the labor of our hands and the compassion of our hearts.
For additional information, please visit www.acumed.net.
